Phibro Animal Health (PAHC) Declares $0.12 Quarterly Dividend; 2.3% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Phibro Animal Health (PAHC) Tops Q1 EPS by 7c, Revenues Beat; Offers 2Q Revenue Guidance Below Consensus, 2Q EPS Mid-Point Guidance Below Consensus
February 3, 2021 4:48 PM ESTPhibro Animal Health (NASDAQ: PAHC) reported Q1 EPS of $0.34, $0.07 better than the analyst estimate of $0.27. Revenue for the quarter came in at $206 million versus the consensus estimate of $205.48 million.
Highlights for the December 31, 2020 quarter (compared to the quarter ended December 31, 2019)
Net sales of $206 million, a decrease of $8 million, or 4%Net income of $13 million, an increase of $1 million, or 8%Diluted EPS of $0.32, an increase of $0.03, or 10%.Adjusted EBITDA of $29... More